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An analytical strategy using fast atom bombardment (FAB) ionization and tandem mass 
spectrometry has been developed to determine the molecular weight and major fragment 
ions, and to provide limited structural characterization of low picomole levels of 
carcinogen-nucleoside adducts. This strategy consists of three main components: (1) the 
sensitivity for analysis by FAB combined with mass spectrometry is increased via chemical 
derivatization; (2) the nucleoside adducts are selectively detected by using constant neutral 
loss scans; and (3) structurally characteristic fragments are obtained by using daughter ion 
scans. Trimethylsilyl derivatized arylamine-nucleoside adducts have been detected at levels 
as low as a few picomoles by using this approach. After experimental determination of the 
mass of the BHZ fragment ion, daughter ion spectra have been used to probe the structure 
specificity associated with collision-activated decomposition of this fragment. With model 
C-S substituted arylamine adducts [N-(deoxyguanosin-8-yl)-4-aminobiphenyl,N-(deoxy- 
adenosin-B-yl)-4-aminobiphenyl, and N-(deoxyguanosin&yl)-2-aminofluorene], 
nucleoside-specific and carcinogen-specific fragmentation have been observed in daughter 
ion spectra. (1 Am Sot Mass Spectrum 1992, 3, 360-371) 
A central tenet of cancer research is that cova- lent carcinogen-DNA adducts are associated with the risk of developing tumors [l]. Not 
surprisingly, it has been suggested that these adducts 
could be used as biological dosimeters of exposure to 
chemical carcinogens. This approach offers sign&ant 
advantages over traditional methods of risk assess- 
ment, such as environmental monitoring [227]. This 
use of carcinogen-DNA adducts, however, is critically 
dependent upon the development of analytical meth- 
ods that allow their identification and quantification at 
very low (picomole) levels [l]. 
Methods to measure DNA adducts in human tis- 
sues have employed enzyme immunoassays [8-131, 
fluorescence assays [ll, 141, and “2P-postlabeling [8, 
15-171. The principal advantage of these techniques is 
their great sensitivity. For example, the 32P-postlabel- 
ing method has the capability to detect minute quanti- 
ties of adducts, perhaps one adduct in 10” nu- 
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cleotides [X3]. Nevertheless, identifications using this 
method are generally based on cochromatography 
with known standards, and at best, only tentative 
identifications can be made for unknown adducts. 
The other widely used technique, immunoassay, in- 
volves the use of antibodies raised against either the 
specific carcinogen-modihed DNA or nucleoside 
adducts coupled to a protein carrier [19]. Methods 
based on immunoassay suffer from some limitations 
when applied to the identification of unknowns. 
False-positive conhrmations may arise due to cross 
reactivity with structurally similar adducts. Also, un- 
known adducts will likely not elicit a response to a 
specific antibody derived from a carcinogen of unre- 
lated structure, and thus remain undetected. This 
combination of exquisite sensitivity and poor struc- 
ture specificity has resulted in the isolation of carcino- 
gen-DNA adducts that can be detected but not identi- 
fied (see ref 8 for example). 
Electron impact mass spectrometry (EI/MS) has the 
sensitivity to detect comparably low levels of volatile 
organic compounds. This technique has not been suc- 
cessfully applied to the analysis of carcinogen-mod- 
ified deoxynucleosides isolated from tissue DNA, even 
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when the compounds are derivatized to increase 
volatility. Chemical ionization mass spectral methods 
for the detection of specific DNA adducts have been 
reported, especially with electrophore labels to en- 
hance negative ion formation [20-221. Typically, the 
sugar is removed to enhance volatility prior to elec- 
trophore derivatization. Giese and co-workers [20, 21) 
accomplished this using sequential oxidation and re- 
duction prior to derivatization. Similarly, Swenberg 
and co-workers [22] have used gas chromatography/ 
mass spectrometry (GC/MS) with negative ion chemi- 
cal ionization (NICI) to analyze trace levels of N2-3- 
ethenoguanine following electrophore derivatization. 
Fast atom bombardment (FAB) ionization has been 
shown amenable to the identification of microgram 
levels of purified nucleosides [23-251 and carcinogen- 
nudeoside/nucleotide adducts [26]. We have reported 
the identification of deoxynucleoside/nucleotide 
adducts based, in part, on analysis by FAB combined 
with mass spe&ometTy (FAB/MS) [27-301. Unfortu- 
nately, for applications involving the analysis of tissue 
samples, microgram quantities of adducts cannot eas- 
ily be obtained. Thus, we have become interested in 
methods that allow the identibcation of unknown 
carcinogen-deoxynucleoside adducts at levels in the 
1- 10 ng range. 
Trimethylsilylated derivatives of deoxynucleoside- 
carcinogen adducts show surprising sensitivity by 
FAB/MS, possibly even greater than EI/MS [27, 311. 
For example, the adduct reported in ref 27, N-(de- 
oxyadenosin-8-yl)-4-amino-3-chlorobenzyl alcohol, 
was correctly identified after FAB/MS analysis of the 
silylated derivative but not by using El/MS. Recent 
results from Schram’s laboratory [32, 331 show sur- 
prisingly low level detection for silylated derivatives 
of related compounds, including ribonucleosides and 
ribonucleotide monophosphate derivatives by 
FAB/MS. This approach is analogous to the elec- 
trophore derivatization methods used to enhance the 
detection of alkylated nucleosides and bases using 
NICI mass spectrometry [34], or electron capture GC 
I351. 
In this article we report the development of FAB 
combined with tandem mass spectrometry method- 
ologies for the analysis of derivatized arylamine-de- 
oxynucleoside adducts at levels as low as 1 ng. The 
adducts are converted to trimethylsilyl (TMS) deriva- 
tives and examined by using FAB ionization and con- 
stant neutral loss (CNL) scans. FAB ionization pro- 
vides a characteristic mass spectral fragment-marker 
ion (sugar loss) that can be used in CNL scans to 
search for potential nucleoside adducts. Subsequent 
daughter ion scans, using the experimentally deter- 
mined BH: fragment ion rather than the protonated 
(or deprotonated) molecule ion, are then used to pro- 
vide evidence for adduct structures. This method is 
applicable even when the mass selected parent ion 
cannot be identified/recognized in the normal FAB 
mass spectrum. Results obtained by using underiva- 
tized adducts and soft ionization methods other than 
FAB/MS are reported for comparison. Preliminary 
accounts of our work have been presented [36-381. 
Experimental 
Adduct synthesis. N-(2’-deoxyguanosin-8-yl)-4- 
aminobiphenyl was synthesized by a mod&cation of a 
published procedure [39] and then purified by prepar- 
ative high-performance liquid chromatography 
(HPLC). N-(guan-&yl)-4-aminobiphenyl and N-(guan- 
8yl)-4-aminobiphenyl-d, were synthesized by reac- 
tion of 4-aminobiphenyl or 4-aminobiphenyl- 
2,2’,3,3’,4,5,5’,6,6’-d, with guanine-N-oxide in 1O:l 
dimethyl sulfoxide/dimethylformamide at room tem- 
perature overnight. The other adducts were obtained 
from Frederick A. Beland and Fred F. KadIubar of the 
National Center for Toxicological Research. 
Derivafhtion procedure A. Measured portions of the 
adduct were added to tapered glass vials and the 
ethanol solvent was removed with dry argon gas. 
The silylating reagent (N-methyl-N-trimethyl-silyltri- 
fluoroacetamide [MSTFA], N,O-bis(trimethybilyl)tri- 
fluoro-acetamide [BSTFA], or N-methyl-N-(ferl- 
butyldimethylsilyl)-trifluoroacetamide [MTBSTFA]) in 
acetonitrile or dimethylformamide (1:l v/v) was then 
added under argon and allowed to react l-2 h at 
room temperature or at 60-100 “C for 1 h. 
Derivatization procedure B. Adducts were silylated by 
adding the reagent directly to the dry sample and 
heating at 60-100 “C for l-2 h. Mass spectral analyses 
were performed directly on the resulting solutions 
containing the derivatized sample dissolved in the 
derivatizing reagent. 
Thermospray mass spectromety (TS/MS). TS mass 
spectra were obtained by using a Finnigan MAT (San 
Jose, CA) TSQ-70 triple stage quadrupole mass spec- 
trometer equipped with a Finnigan TS controller and 
source. An ISCO (Lincoln, NE) LC-5000 syringe pump 
connected to a Rheodyne 7125 injector (20 pL loop) 
provided a flow rate of - 1.5 mL/min. The mobile 
phase typically was 8B-90% aqueous buffer (0.1 M 
ammonium acetate and methanol). The vaporizer 
temperature was adjusted to a cool setting (- 90 “C) 
to maximize abundance of the protonated molecule. 
Desorption chemical ionization (DC11 mass spectra. DCI 
mass spectra were obtained with a Finnigan MAT 
4023 operating in the CI mode with methane or 10% 
ammonia in nitrogen as the reagent gas. Samples 
were introduced via a Vacumetrics (Ventura, CA) or a 
custom-made DC1 probe incorporating a platinum 
filament heated at a rate of 50 mA/s for 60 s. The 
reagent gas was set to an uncorrected nominal source 
pressure of 0.25 torr. The source temperature was 
200-220 “C. 
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FAB mass spectrometry. Samples were applied di- 
rectly to a copper target via a syringe (0.5-1.0 flL) 
after application of 1-2 rL of thioglycerol FAB matrix 
liquid. Spectra were obtained by using a Finn&an 
MAT TSQ-70 with an Ion Tech (Middlesex, UK) gun. 
FAB ionization was effected by using xenon atoms 
accelerated to 8-10 keV. Scans were obtained from 
about 900 u down to about 70 u under control of the 
TSQ-70 data system. 
FAB/MS/MS. (a) Constunt neutral loss scans were 
acquired by using the Finnigan MAT TSQ 70 as de- 
scribed above for FAB/MS. To obtain a constant neu- 
tral loss scan the hrst and last quadrupoles, Ql and 
Q3, were scanned at the same rate with a constant 
mass offset corresponding either to the mass of a 
deoxyribose moiety (116 u) or a his-TMS derivatized 
deoxyribose (260 u). (b) Daughter ion scans were ob- 
tained by hxing the mass passed by Ql to correspond 
to the protonated molecule, the BH: ion, or a TMS 
derivative of the former, while the mass of Q3 was 
scanned to detect the masses of all fragments formed 
by decomposition of the mass selected parent ion. 
Both types of scans were acquired by using argon as 
the collision gas to induce decomposition of the par- 
ent ion. Collision energies of 30-90 eV were utilized 
and collision cell pressures were varied to maximize 
the yield of useful daughter ions. 
Results and Discussion 
Sensitivity Studies 
The initial objectives of the sensitivity studies were: 
(a) to demonstrate that FAB/MS is a sensitive soft 
ionization methodology for the analysis of carcino- 
gen-modified deoxynucleosides; and (b) to optimize 
experimental conditions so that full-scan spectra could 
be obtained by using minimum amounts of sample. 
The analysis of carcinogen-DNA adducts from in vivo 
rather than in vitro studies is currently hindered by 
the inability to routinely obtain mass spectra from low 
nanogram to picogram levels of samples. 
Comparison of ionization methods. To address the first 
objective, mass spectra of the model adduct N-(de- 
oxyguanosin-B-yl)-4-aminobiphenyl (dG-C%ABP, Fig- 
ure 1) were obtained by using DCI, TS, and FAB 
ionization. [This adduct, the principal modified nucle- 
oside isolated from urinary bladder DNA upon expo- 
sure to the arylamine carcinogen 4-aminobiphenyl 
(ABE’), is attributed to a reaction between DNA and a 
reactive metabolite, namely N-hydroxy-ABE’.] Analy- 
ses were attempted by using 1 pg, 500 ng, 200 ng, 100 
ng, and 10 ng of adduct with each of the ionization 
techniques. Typically, spectra were obtained by scan- 
ning from 600 u down to 100 m. The nominal sample 
sizes giving reproducible full-scan spectra under the 
conditions described above are enumerated in Table 
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dA dG~C8-ABP 
dA dA-CEABP 
(mw = 434) 
(mw = 446) 
(mw = 4881 
dh dG-CB-AAF 
Figure 1. The structures of model nucleoside-carcinogen 
adducts used in this study: N-(deoxyguanosin-gyl)-4-aminobi- 
phenyl, dG-CS-ABP; N-(deoxyguanb~n-S-yl)-2-aminofluorene, 
dG-CE-AF; N-(deoxy-adenosin-8.yl)-4aminobipheny1, dA-C8- 
ABE’, and N-(deoxyguanosin-8-yI)-2-acetylaminofluorene, dG- 
CB-AAF. 
1. For each ionization technique, the lowest limit of 
detection was 100 or 200 ng. Figure 2 shows a typical 
spectrum obtained from the analysis of 100 ng of 
dG-C8-ABP by using FAB ionization. The protonated 
molecule and BH: ion are detectable above the near 
continuous background signal attributed to the FAB 
matrix liquid (thioglycerol). Moser and Wood [24] and 
Weng et al. [32] have reported comparable detection 
limits (250-500 ng) for unmodified nucleotides by 
FAB/MS using p-toluenesulfonic acid/glycerol or 
glycerol as ma&ix compounds. 
For comparison the experiment was repeated by 
using dG-C&ABE’ derivatized to incorporate TMS 
groups. Solutions of the derivatizing reagent, a sol- 
vent, and the adduct were prepared so that the ap- 
propriate amounts of adduct (1 pg to 10 ng) could be 
analyzed directly from the derivatization solution. 
TS/MS was not used in this comparison as the deriva- 
tized adducts were not expected to be stable in an 
aqueous solution. Procedure A was used for derivati- 
zation with MSTFA. Mass spectra were acquired over 
a wide mass range (900 u) to simulate the experimen- 
tal conditions appropriate for the examination of un- 
known adducts. For example, the molecular weight of 
the tetmkis-TMS derivative of a deoxyguanosine 
adduct of a carcinogen having a molecular weight 
above 350 u would exceed 900 u. 
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Table 1. Compilation of the minimum amount of carcinogen-nucleoside adduct needed 
to obtain full-scan mass spectra by using various soft ionization mass spectrometery methods 
Method Adduct 
DCI/tvlS= dG-C 8-ABP 
DCI/MS’ dG-C ~-ABP 
TS/MS dG-CB-ABP 
FAB /MS dG-CB-ABP 
DCI/MSc dG-C&ABP 
DCI/MSd dGC8-ABP 
FABjMS dG-C8ABP 
FAB/MS dG-CB-AF 
FAB/MS dG-CB-AF 
Derivativea 
- 
- 
- 
- 
MSTFA (A) 
MSTFA (AI 
MSTFA (A) 
MSTFA (AI 
MSTFA (B) 
Amountb Figure 
200 ng - 
200 ng _ 
200 ng - 
100 ng 2 
200 ng 3 
200 ng - 
long 4 
8ng 5 
1 “9 - 
Abbreviations: DCI = desorption chemical ionization; 
FAB = fast atom bombardment ionization; 
MSTFA = N-methyl-N-trimethylsilyl-trifluoroacetamide: 
ng = nanograms: 
TS = thermospray ionization. 
‘A and B refer to the derivatiration procedures (see Experimentall. 
bApplied to the probe tip. 
= Methane reagent gas. 
dAmmonia reagent gas. 
Incorporation of TMS groups did not significantly 
reduce the amount of adduct needed to produce spec- 
tra using DCI/MS with either methane or ammonia as 
the reagent gas. Typical of these results is the methane 
DC1 mass spectrum shown in Figure 3. About 200 ng 
of dG-CB-ABP derivatized with MSTFA/DMF was 
required to obtain reproducible spectra. While the 
protonated molecules for the tris- and tetrakis-TMS 
containing derivatives (m/z 651 and 723) were ob- 
served, the fragment ions corresponding to TMS con- 
taining BHf ions (m/z 391 or 463) were not. The ions 
at m/z 487, 413, and 307 have not been identihed. 
In contrast to the DC1 work, FAB mass spectra 
were obtained by using smaller amounts of silylated 
adduct. Figure 4 shows the FAB mass spectrum ob- 
tained when a lOO-ng sample of dG-C8-ABP was 
derivatized (Procedure A) and 10% (10 ng) applied to 
the probe tip for analysis. The ions at m/z 651 and 
400 600 
dZ 
Figure 2. The FAB mass spechum obtained by using 100 ng of 
dG-CEkABP showing the protonated molecule (m/z 435) and 
BHZ ion (m/t 319). 
579 correspond to the protonated molecules for the 
tris- and &is-TMS derivatives, whereas the ion at m /z 
391 corresponds to the mono-TMS derivative of the 
BH: fragment ion. This fragment could occur via loss 
of a bis-silylated deoxyribose from m/z 651 or via loss 
of a monosilylated sugar from m/z 579. Based on 
previous reports of complete silylation of the deoxyri- 
bose moiety, even with incomplete derivatization of 
the carcinogen/base moiety, the forme+ pathway ap- 
pears to be more likely [40]. The unsilylated fragment 
ion, BH:, was also observed at m/z 319 but is not 
displayed in Figure 4. This ion is attributed to loss of 
the disilylated deoxyriiose moiety ‘from those bis- 
silylated adduct protonated molecules having both 
TMS groups attached to the sugar. 
Ill/L 
Figure 3. The methane DC1 mass spectrum obtained by using 
200 ng of dG-C&ABP derivatized with MSTFA/dimethylfor- 
mamtde showing protonated molecules for the tetmkis-TMS 
derivative (m/z 723) and the tris-TMS derivative (m/z 651), as 
well as a BH i ion with no Th4S groups (m/t 319) 
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m/l 
Figure 4. The FAB mass spectrum obtained by using 10 ng of 
dG-C&ABP derivatized with MSTFA/dimethylformamide 
showing protonated molecules for the tris-TMS (m/z 651) and 
his-TMS species (m/r 579) and a BHZ fragment ion containing a 
single TMS group (m/z 391). 
Optimization of derivatization conditions and comparison 
with other adducts. Similar experiments were also 
performed by using other adducts and other derivati- 
zation reagents. Figure 5 shows the spectrum ob- 
tained from 5 ng of N-(deoxyguanosin-8-yl)-2- 
aminofluorene, dG-CB-AF, derivatized with MSTFA 
(Procedure B). The ions at m/z 663 and 591 corre- 
spond to the tris- and bis-TMS containing protonatcd 
molecules, whereas m /z 403 and 331 are the BH; 
fragments having one and no TMS groups, respec- 
tively. For comparison, the m/z 217 ion corresponds 
to the protonated thioglycerol matrix dimer. It should 
be noted that this matrix background ion is about 200 
times smaller relative to the analyte protonated 
molecule ions using 5 ng of derivatized adduct (Figure 
5) than when using 1 fig of underivatized adduct 
(Figure 6). This shows the striking improvement in 
YH‘ MSI. 
163 
.k I,. 
I 
200 400 800 800 
MZ 
Figure 5. The FAB mass spectrum obtained by using 5 ng of 
MSTFA derivatized dG-C8-AF showing protonated molecules 
for the tris- and his-TMS containing ions (m/z 663 and 591) as 
well as the BH: TMS ion (m/z 403) and the BHZ ion (m/t 
331). 
I.. 
1 
200 300 400 500 600 700 BOO 
FlliZ 
Figure 6. The FAB mass spectrum obtained by using 1 JL~ of 
underivatiaed dG-C8-AF showing the pratonated molecule (m/r 
447), the BH: (m/z 331), and the relatively large contribution of 
the matrix ion at M/Z 217. 
the analyte to matrix signal levels observed with 
derivatized adducts as compared to their underiva- 
tized forms. The relative abundance of the analyte 
protonated molecules with respect to the thioglycerol 
matrix ion (m/z 217) is even more surprising when 
the partitioning of the molecular signal among the 
two TMS derivatives (m /z 663 and 591) is considered. 
In a related study, Schram and co-workers 1321 
reported a method for the analysis of low nanogram 
levels of clinically important nucleotide-monophos- 
phates by FAB/MS. Derivatization was accomplished 
in capillary tubes by using small volumes of BSTFA in 
pyridine. Analysis by EI and Cl/MS indicated com- 
plete derivatization of the ribose monophosphate moi- 
ety, but not the base. They observed the loss of TMS 
groups, which they attributed to hydrolysis, by using 
either glycerol or 3nitrobenzyl alcohol (NBA) as a 
FAB matrix liquid. One TMS group was lost with 
NBA, whereas more extensive hydrolysis and low 
signal levels were reported for glycerol. Hydrolysis 
was not observed with tetraglyme, but other experi- 
mental difficulties, including lack of sensitivity, lim- 
ited its use as a FAB matrix. No results for thioglyc- 
erol were reported. 
We also see evidence for hydrolysis with FABjMS 
using thioglycerol. Differences in the number of TMS 
groups are observed when TMS derivatized adducts 
are analyzed by DCI/MS and FAB/MS (Figures 3 and 
4, for example). However, the number of TMS groups 
appears constant from scan to scan via either method, 
suggesting that hydrolysis occurs rapidly and to com- 
pletion prior to introduction of the sample into the ion 
source. ln other words, matrix induced hydrolysis 
likely occurs almost immediately upon introduction of 
the sample into the FAB matrix liquid. 
If the DC1 mass spectrum is assumed to accurately 
reflect the number of TMS groups added prior to 
introduction of the analyte into the FAB matrix liquid, 
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the number of groups expected by FAB/MS without 
hydrolysis would be 3-4. The addition of this number 
of TlvlS groups, although it represents incomplete 
derivatization, is in good agreement with a previous 
study of carcinogen-nucleoside adducts using BSTFA 
and EI/MS [41]. The TMS derivatization of a similar 
C&substituted deoxyguanoslne adduct produced tris- 
and tetrakis-TMS derivatives with a ratio of about 1:2. 
In our work we have typically observed his- and 
tris-TMS derivatives in about the same ratio (i.e., 
Figures 4 and 5). These data suggest that only one 
TMS group is lost via hydrolysis in thioglycerol. This 
is a lesser extent of hydrolysis than was attributed to 
the use of glycerol in ref 32, and is more consistent 
with the results reported for NBA. In other words, we 
attribute the observation of partially derivatized 
DNA-carcinogen adducts in thioglycerol to two 
causes. Fist, typical arylamine nucleoside adducts are 
not likely to be completely derivatized prior to their 
introduction into the matrix. Subsequently the thio- 
glycerol matrix also induces loss of approximately one 
additional TMS group. The derivatization procedure 
may slightly affect the extent of this hydrolysis. When 
pure MSTFA is used for derivatlzation, the subse- 
quent FAB spectra sometimes show a small increase 
in the tris-TMS derivative relative to the his-TMS 
derivattied adduct. For example, the FAB/MS spec- 
trum shown in Figure 4 was obtained by using 1:l 
MSTFA/dimethylformarnide, whereas Figure 5 repre- 
sents derivatization in pure MSTFA. By either method, 
FAB/MS analysis of the TMS derivatives gives about 
the same detection limit in thioglycerol previously 
reported for NBA. 
In another recent report, Vorous and co-workers 
[31] showed FAB/MS spectra of TMS derivatives of 
deoxynucleoside-carcinogen adduds. They reported 
extensive hydrolysis using thioglycerol, based on the 
presumption that the adducts were initially com- 
pletely derivatized. However, they showed no evi- 
dence regarding the extent of derivatization prior to 
FAB/MS analysis. Based on results already cited from 
ref 41, as well as a review of the EI/MS data for 16 
silylated deoxynucleoside-arylamine adducts [40], the 
assumption of complete derivatization prior to analy- 
sis by FAB/MS may have been incorrect. Neverthe- 
less, the FAB mass spectra in ref 31 are very similar to 
those we report. For example, a spectrum obtained by 
using 67 ng of TMS derivatized dG-CBAF was very 
similar to Figure 5, obtained by using 5 ng. One 
notable difference is that the extent of hydrolysis is 
slightly greater in all of the FAB mass spectra reported 
in ref 31. Vouros’s group reported that the &TMS 
protonated molecule was always larger than the tris- 
TMS species under the conditions they described, 
whereas we often see the opposite. More interesting 
is the report of better results by using thioglycerol 
rather than NBA as a FAB matrix. 
Derivatization with MSTFA, BSTFA, and MTB- 
STFA produced similar improvements in sensitivity in 
our experiments. FAB/MS spectra were readily ob- 
tained by using 5 ng of dC-C8-AF derivatized with 
MTBSTFA (spectrum not shown); however, the abun- 
dance of the protonated molecule was relatively small. 
The this-(dimethyl, teti-butylsilyl) (DMTBS) deriva- 
tired protonated molecule was observed at m/z 789 
as was a mono-DMTBS BHZ ion (m/z 445) ion at- 
tributed to loss of the his-DMTBS derivatized sugar. 
The his-DMTBS protonated molecule (m/z 675) was 
not observed and the BH: ion was less intense than 
either m/z 789 or 445. Numerous other ions in the 
spectrum were not identified. A particular problem 
with MTBSTFA derivatization was that for each 
DMTBS group added, the adduct increased in mass 
by 114 u rather than the 72 u for TMS. Hence, a 
DMTBS derivatized nucleoside-carcinogen adduct in- 
cluding a large carcinogen could exceed 1000 u in 
mass. 
A major limitation upon reduction of the sample 
sizes for mass spectral analysis was dilution of the 
adducts in the derivatization reaction mixture. The 
derivatization procedure was changed by omitting the 
cosolvent to reduce the overall sample voIume (Proce- 
dure B, Experimental). In subsequent experiments the 
derivatizing reagent was added directly to the dry 
nucleoside-adduct residue in a small conical vial. Us- 
ing this procedure it was possible to derivatize as little 
as 2 ng of the modified nucleoside with 2 PL of 
MSTFA and to then remove 1 pL for analysis. The use 
of pure MSTFA may also have resulted in a minor 
reduction in the extent of hydrolysis, as indicated 
above. This same approach has been proposed in ref 
31. In that article the authors recommended derivati- 
zation of 200 ng of adduct using 10-20 PL BSTFA 
[32]. However, they also apparently observed more 
hydrolysis. We have observed similar results by using 
other arylamine adducts, namely, N-(deoxyadenosin- 
8yl)-4-aminobiphenyl (dA-C%ABP), and N-(de- 
oxyguanosin-&yl)-2-acetylaminofluorene (dG-CS- 
AAF) (spectra not shown). 
Constant Neutral Loss Scans 
The use of CNL scans for the analysis of modified 
nudeosides was also evaluated. By using this ap- 
proach all of the ions that arise via a mass loss 
corresponding to the deoxyribose moiety can then be 
identified. The characteristic cleavage to produce the 
PH,I + ion has been observed in mass spectra ob- 
tained from protonated nucleosides/nucleotides 
[23-251, carcinogen-modifted nucleosides [26, 30, 311, 
and silylated carcinogen-mod&ed nucleosides [27,31]. 
We have recently reported the successful application 
of CNL scans (116 u) to the identification of an un- 
known carcinogen-nucleoside adduct. When HPLC 
separated fractions from the in vitro reaction of DNA 
with a nitro-PAH metabolite, 2nitropyrene, were ex- 
amined by using CNL scans, two adducts were iden- 
tified. One of these was an unusual C&modified 
366 BRYANT ET AL. 
deoxyadenosine adduct [30]. By using the same ap- 
proach, Claeys and co-workers [42] have demon- 
strated the utility of CNL scans for the analysis of 
nucleosides of phenyl glycidyl ethers. They reported 
detection limits of about l-10 ng. Because daughter 
ion scans of the protonated molecule were not partic- 
ularly characteristic of parent ion structures, they used 
daughters of the [M-H]- ion, in the negative ion 
mode, for structure characterization, whereas we em- 
ploy BH: ions for the same purpose. 
Of particular importance to our study was whether 
the CNL scan method would allow additional reduc- 
tion in the minimum amount of sample needed for 
the analysis of nucleoside-carcinogen adducts by mass 
spectrometry. As the signals for the protonated 
molecule and the BH$ ion become weaker at lower 
concentrations, confirmation of the relationship be- 
tween these two ions, in unknown samples, becomes 
increasingly difficult and important. Moreover, any 
improvement in sensitivity relative to that obtained by 
using full-scan FAB/MS of MSTFA derivatives would 
allow detection of adducts at levels approaching 1 
pmol. 
Underivufized adducts. Underivatized adducts were 
examined by using CNL scans (116 u) to determine if 
the observation of parent ions showing loss of the 
deoxyribose moiety was possible at levels too low to 
obtain full-scan FAB mass spectra. Whereas full-scan 
spectra required the analysis of 100 ng of underiva- 
tized adducts, the use of these CNL scans allowed 
adducts to be detected at levels as low as 5 ng (Table 
2). Figure 7 shows a FAB CNL mass spectrum ob- 
tained by using 5 ng of dG-C8-AF. The protonated 
molecule at m/z 447 is the largest peak in the spec- 
trum. The other signals are attributed to the high 
noise level at this lower limit of detection. Similar 
results have been obtained by using 8 ng of N-(de- 
oxyadenosin-8-yl)-4-aminobiphenyl, dA-C8-ABP 
(spectrum not shown). 
Derivatized adducts. Significant reduction in the noise 
level was observed in CNL scans (260 u) of MSTFA 
derivatized adducts. With FAB ionization, CNL scans 
were readily obtained by using l-5 ng of MSTFA 
J Am Sot Mass Spectrom 1992,3,360-371 
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Figure 7. The FAB/CNL spectrum (116 u) obtained by using 5 
ng of dG-CS-AF showing the loss of the deoxyribose moiety 
from the parent ion (protonated molecule) at m/z 447. 
derivatized dG-C8-AF. Because a derivatized nucleo- 
side was examined, the CNL was 260 u rather than 
116 u, corresponding to the mass of a his-TMS con- 
taining deoxyribose moiety. Typical of these results is 
the spectrum obtained by using 1 ng dG-C8-AF (Fig- 
ure 8). The ions at m /z 591 and 663 correspond to the 
protonated molecules of the his- and this-TMS deriva- 
tives, whereas the ions at m/z 484 and 412 are at- 
tributed to loss of the AF moiety during derivatiza- 
tion. (The facile cleavage of the carcinogen from TMS 
derivatives of arylamine-nucleoside adducts, espe- 
cially C-S substituted deoxyguanosine derivatives, has 
been reported elsewhere [40].) These results should 
be contrasted to those shown in Figure 5, obtained by 
using 5 ng of MSTFA derivatized adduct via FAB/MS. 
Satisfactory constant neutral loss scans were consis- 
tently obtained by using smaller amounts of sample 
when the adducts were TMS derivatized. However, 
the extent of enhancement observed upon TMS 
derivatization was less with CNL scans (Table 2) than 
expected based on the results obtained by using 
FAB/MS (Table 1). 
Analysis of unknown adducts. We have already re- 
ported the application of CNL scans to the identifi- 
Table 2. Typical sample sizes needed to obtain FAB CNL spectra for loss 
of 116 u (the deoxyribose moiety) or 260 u (the his-TMS derivatiied deoxyribose) 
from the protonated molecule of carcinogen-nucleoside adducts 
CNL mass 
Adduct Derivative loss Amount8 Figure 
dG-C8-AF - 116 5 ng 7 
dAC8A8P t16 8 ng 
dG-CB-AF MSTFA 260 1 ng 8 
Abbreviations: CNL = cons&t neutral loss; 
FAQ = fast atom bombardment ionization: 
MSTFA = N-methyl-N-trimethylsilyl-trifluoroacetamide; 
ng = nanograms. 
‘Applied to the probe tip. 
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Figure 8. The FAB/CNL spectrum (240 u) obtained by using 1 
ng of dG-Ctl-AF derivatiwd with MSTFA. 
cation of unknown carcinogen-DNA adducts from 
nitropyrene metabolites 1301. Another recent experi- 
ment also demonstrates this application. Several iso- 
lated HF’LC fractions, some containing carcinogen- 
modified DNA, were submitted to the laboratory for 
identification. Prior to mass spectral analysis the DNA 
was reacted with the N-hydroxy derivative of the 
heterocyclic aromatic amine 2-amino-l-methyld- 
phenylimidazo[4,5-blpyridine (PHiF), the modified 
DNA was hydrolyzed to the nucleosides, and HPLC 
fractions containing UV adsorbing peaks with reten- 
tion times consistent with modified nucleosides were 
collected. The individual fractions were dried, TMS 
derivatized, and submitted to the laboratory as un- 
knowns. The CNL scan (260 u) obtained from one of 
the fractions is shown in Figure 9. The intense ion at 
m/z 706 corresponds to the tris-TMS derivative of 
dG-C8-PHP. Additional evidence for this assignment 
was obtained by comparison of daughter ions from 
the BHZ ion (m/z 374) and synthetic G-C8-PHiP. 
Figure 9. The FAB CNL spectrum (260 u) of an unknown 
HPLC separated component from the hydrolysate of N-hy 
droxy-PHiP treated DNA. 
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Daughter Zon Scans 
The use of daughter ion scans to provide evidence 
regarding nucleoside-adduct structures was also in- 
vestigated. For unknowns, even modest details re- 
garding adduct structure could be extremely useful. 
For example, identihcation of a specihc base would 
allow the weight of the carcinogen to be deduced. The 
MS/MS methodology is widely accepted as a means 
of detecting trace components in complex mixtures 
[43]. Vouros and co-workers 1311 have developed a 
method for the detection of specific carcinogen-DNA 
adducts a the 100 ng level based on TMS derivatiza- 
tion, FAB/MS analysis, and, fmally, B/E linked scans. 
Our method differs primarily based on the use of a 
CNL scan rather than FAB/MS in the hrst step of 
mass spectral analysis. These CNL scans simplify the 
identihcation of the parent ions that are used in the 
second step of identification based on daughter ion 
scans. We also note some differences in daughter ions 
obtained by using a triple quadrupole mass spectro- 
meter and low energy collisional activation (CA), de- 
scribed below. 
The typical procedure for characterizing analyte 
structures via soft ionization and MS/MS is CA of the 
analyte protonated molecule. For underivatized ary- 
lamine-nucleoside adducts this produces an intense 
BH; ion. For example, the daughter ion spectrum 
obtained when the protonated molecule (m /z 447) of 
dG-Ct3-AF was mass selected and collisionally acti- 
vated showed a single major fragment ion at m/z 331 
(spectrum not shown). Similar results were observed 
with the other model arylamine-nucleoside adducts. 
This fragment ion provides no additional evidence 
regarding the adduct’s structure beyond that also 
observed in the FAB/MS and FAB CNL scans. 
With derivatized adducts the results were similar. 
The daughter ions of the mono-TMS derivative of 
dG-CS-AF included a BHZ ion at m/z 331 and a 
TMS-BHZ ion 72 u higher in mass at m/z 403. This 
spectrum (Figure 10) illustrates two important points. 
First, as with underivatized nucIeoside-adducts, 
100 
1 
a*; 
331 
I 
80 -I 
f 
= Bo- 
9 
d 40- 
*o- 
0' 
100 150 200 250 300 350 400 450 JO0 650 800 
Figare 10. The FAB daughter ion spectrum from the proto- 
nated molecule (m/z 519) of the mono-TMS derivative of dG- 
C8-AF. 
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daughter ions from the protonated molecule do not 
provide additional data regarding adduct substruc- 
ture. Second, derivatization complicates interpreta- 
tion when an adduct containing TM5 groups may 
include more than one isomer. The ion at m /z 403 in 
Figure 10 must have arisen via the loss of an unde- 
rivatked sugar from a protonated molecule having 
the TMS group attached to the base or the AF moiety. 
On the other hand, the ion at m/z 331 must have 
arisen from a protonated molecule having a TMS 
group on the sugar but not the base or carcinogen 
moiety. 
A simple strategy was developed to avoid prob- 
lems associated with the formation of isomers accom- 
panying the TMS derivatization step. Derivatized 
adducts were used to obtain CNL (260 u) and daugh- 
ter ion spectra; but the speciftc daughter ions were 
underivatized BH$ fragments rather than TMS-con- 
taming protonated molecules. The incomplete deriva- 
tization of the carcinogen/base moiety and the loss of 
one TMS in the FAB matrix liquid have resulted in the 
observation of non-TMS containing BHZ ions from all 
of the MSTFA derivatized carcinogen-nucleoside 
adducts examined in our laboratory. Fortuitously, for 
carcinogen-deoxynucleoside adducts, the BH; ions 
show considerably more structurally characteristic 
fragmentation than protonated molecules [31]. Be- 
cause the carcinogen is invariably bound to the base 
rather than the deoxyribose moiety in carcinogen- 
DNA adducts, this strategy should not result in loss 
of structure specificity. The observation that daughter 
ion spectra from several protonated G-C8-adducts are 
indistinguishable from the daughters of the corre- 
sponding BH: fragments supports this hypothesis. 
For example, the daughters of the BH$ fragment ion 
of dG-C8-ABP and the protonated molecule of the 
corresponding carcinogen base adduct (N-@an-8-yl)- 
4-aminobiphenyl) are compared in Table 3. 
Table 3 shows the masses of sign&ant daughter 
ions observed from the BHZ of dG-CB-ABP. The 
frequency of occurrence of daughters using various 
collision energies is also reported. Subjective review 
of these data, and the individual daughter ion spectra 
used to prepare Table 3, suggested that although 
there was significant variability between spectra at all 
collision energies, 50-eV collisions generally produced 
more abundant and reproducible fragmentation. To 
provide consistency this value was subsequently used 
in the remaining daughter ion experiments. 
A daughter ion spectrum obtained by using the 
BH: ion from 20 ng of dG-CB-AF derivatized by 
using MSTFA is shown in Figure 11. These results are 
compared in Table 4 with daughters obtained by us- 
ing dG-C8-ABP and are shown in Table 3. Peaks 
Table 3. The frequency of observation of selected daughter ions from the BH: ion 
of dG-CB-ABI’ and a comparison with daughter ions from the protonated molecule 
of synthetic G-0%ABP” 
Ion MZ3S Experiment Number 
mass IOSS 1 2 3 2'b 4c 
302 17 + + + + + 
277 42 3/4 + 2/3 + + 
276 43 214 216 _ 
275 44 - 216 - - + 
249 70 214 + l/3 + + 
247 72 314 5P - + + 
208 111 + 
207 112 + 
195 124 + 
180 139 + 
166 151 - 
165 154 + 
153 166 214 
140 179 + 
+ 
516 
+ 
+ 
516 
+ 
+ 
+ 
+ 
+ 
2/3 
+ 
+ 
113 
+ 
+ 
123 196 + + + + + 
112 207 + + + + + 
105 214 _ 316 _ 
95 224 J/4 + =f3 + + 
Collision 
energy kw 30 50 90 50 50 
aA “t” symbol indicates that daughter ion was detected in all experiments. A fraction indicates the 
frequency with which a daughter ion was observed. 
‘The daughter ions expected more than 50% of the time from a single analysis at 50 eV. 
‘The daughter ions observed from the protonated molecule of G-X-ABP, for comparison 
deV = electron volts, the laboratory value far collision energy. 
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Figure 11. The FAB daughter ion spechum from the BHZ 
fragment ion obtained by using 20 ng of dG-CB-AF derivatized 
with MSTFA. 
labeled a to j occurred via the same neutral losses for 
both of these C-8 substituted deoxy-guanosine 
adducts. This is attributed to fragmentation in which 
the carcinogen is retained within the part of the 
molecule having the positive charge. Experiments us- 
ing a deuterated adduct (dG-CB-ABP-d,) confirmed 
retention of the carcinogen moiety in these fragments. 
Daughter ions including the carcinogen moiety re- 
tamed eight or nine of the nine deuterium atoms 
originally bound to the biphenyl group in the ABE’ 
moiety of the deuterated adduct. 
Other characteristic ions showed the same masses 
rather than identical neutral losses. The ions at m/z 
95, 112, 123, and 140, observed in the spectra of 
dG-CB-AF and dG-CS-ABP, are attributed to frag- 
ments from which the carcinogen moiety has been 
lost. Because the ions a to j resulted from retention of 
the carcinogen moiety, ions resulting from these spe- 
cihc neutral losses should be observed from the BH$ 
ions of all C&dG adducts. Similarly, the ions showing 
loss of the carcinogen should have common masses 
(m/z 95, 112, 123, and 140) for all C8-dC adducts. An 
exception is that because fragment j occurs via cleav- 
age within the carcinogen, it may be specific for C8 
adducts linked to the carcinogen via an amine moiety 
(i.e., arylamines). 
The specific cleavages observed in the daughter ion 
spectrum (see Figure 11) are shown in Scheme I. 
These cleavages were chosen based on the hypothesis 
that for low energy collisions, the even electron BH: 
fragment ion would not fragment via loss of radicals. 
A previous report of radical ions in the FAB mass 
spectra of TM5 derivatives of related compounds was 
attributed to the presence of an Si atom in the TMS 
moiety [33]. Because no TMS groups are present on 
the BH$ ions used as parent ions, radical ions would 
not be expected. The correspondence between the 
spectra for the two dG-C8 adducts, as well as the 
Table 4. Comparison of the major daughter ions in the tandem mass spectra of dG-CB-ABP, 
dG-CBAF, and dA-CB-ABP showinr! common neutral losses OF common fragment massesa 
Mass loss dG-C8-ABPb dG-C8-AF FraamentC dA-C8-ABP 
17 
42 
44 
70 
72 
111 
112 
124 
139 
151 
166 
Mass 
207 
195 
180 
168 
153 
140 
123 
112 
105 
95 
+ + 
+ + 
(2/6) + 
+ + 
(5/W + 
+ + 
+ + 
+ +d 
+ + 
+ +e 
+ c 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+d 
+= 
+ 
+ 
+ 
+ 
+ 
+ 
9 
h 
.i 
i 
-The collision energy flaboratory value) was 50 eV. A “+” indicates the daughter ion or mass loss is 
observed. 
bA “Z/6” indicates that this daughter ion was observed in only two of six replicate analyses. 
‘This term refers to proposed structures for the daughter ions labeled in Figure 11 as shown in 
Scheme I. 
dThis fragment at m/z 207 is attributed to loss of 124 u via cleavage g in Scheme I 
‘This fragment at m/z 180 is attributed to lass of 151 Y via cleavage i in Scheme I. 
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c(-H) 
b(+H) 
- i(+H) 
i f 
‘-h(+H) 
g(+H) 
e(-H) 
d(+H) 
Scheme 1. Proposed fragmentation of the BH,+ ion from dG- 
CS-AF corresponding to peaks labeled a to j in Figure 11 and 
Table 4. 
ready assignment of the carcinogen containing frag- 
ments from the adduct having deuterium isotopes on 
the aromatic hydrogens of the carcinogen moiety, 
provide strong evidence for the assignments in 
Scheme I. However, even if these include errors, the 
daughter ion methodology can be used for structure 
characterization based on the empirically observed 
correlation between neutral losses and fragment ion 
masses with the analyte structures. 
A comparison was made with a mode1 adduct of a 
different nucleoside having the same carcinogen and 
similar carcinogen-base bonding (dA-C&ABE’). The 
daughter ion spectrum (not shown) was obtained by 
using 42 ng of adduct. Most of the dG characteristic 
losses associated with retention of the carcinogen 
moiety in the neutral fragment were not observed 
with the dA adduct (see Table 4). Exceptions are ions 
labeled a and c. These losses, NH, and C,N,H,, are 
relatively small molecules and might be expected from 
either dA or dG adducts. However, some ions are 
common to both the ABP adducts. For example, ions 
labeled g, h, i, and j are attributed to loss of most of 
the base moiety. Any remaining portion of the base 
substructure is identical for dG-CB-ABP and dA-C8- 
ABP, as shown in Scheme I. 
Some confusion may arise because of the coinci- 
dence of daughter ion masses attributed to different 
fragmentation pathways in two of the adducts. The 
ions at m/z 207 and 180 for dG-C8-AF and dG-C& 
ABP are not attributed to the same structures (see 
Table 4). The ions at m /z 207 and 180 in dG-CB-AF 
correspond to loss of 124 and 151 u, respectively, 
from the BH g. Hence, the m /z 207 and 180 ions from 
dG-C8-AF and the m /z 168 and 195 ions from dG-C8- 
ABP would be attributed to the same cleavage within 
the base moiety. The m/z 180 from dG-CB-AF arises 
from loss of the dG moiety to give [C,,H,,N] l . 
These results should be contrasted to those re- 
ported in ref 31. Daughter ions from the BH: ion 
J Am Sot Mass Spectrom 1992, 3, NO-371 
from dG-C8-AF were examined by using high energy 
collisional activation and B/E scans. Significant 
daughter ions were reported at m/z 314, 284, 259, 
232, 206, 191, 180, and 165. The ions at m/z 314, 259, 
232, 180, and 165 are prominent in Figure 11 as well 
These ions, common to both studies, were attributed 
in ref 31 to the same structures we propose in Scheme 
I. The ions at m /z 284, 206, and 191 were observed in 
high energy, but not low energy, collisions. The ions 
at m/z 206 and 191 could be radical fragments result- 
ing from high energy collisions, or they could be 
misassigned in the B/E scan. The authors of ref 31 
pointed out that an error in their daughter ion mass 
assignments of 1 u was possible because of the use of 
linked scans. Because we have observed m jz 207 and 
192 in numerous daughter ion scans from dG-C&AF, 
and this same mass loss (of 124 and 151 u) from 
dG-C&ABP, and dG-C8-AF, under a variety of exper- 
imental conditions, we attribute this difference to an 
error in the linked scan derived daughter ion mass 
assignments. The other ion observed in ref 31, at m /z 
284, was not observed in our experiments, but was 
also attributed to an even electron fragment. These 
results suggest daughter ion spectra obtained by us- 
ing low or high energy collisions provide sufficient 
structure specificity for use in characterizing adduct 
structures, even when the experiments are performed 
in different laboratories. Furthermore, with the excep- 
tion of the two daughter ions in the B/E scans that 
can be attributed to an error in mass assignment, all 
of the daughter ions from the BHZ ions of several 
adducts, in both studies, can be attributed to even 
electron fragmentation. 
Conclusion 
Our methodology combines three experimental ap- 
proaches to the characterization of low levels of car- 
cinogen-deoxynucleoside adducts. The utility of each 
component approach for the analysis of these or re- 
lated compounds by mass spectrometery has been 
previously reported. The method incorporates the use 
of CNL scans for screening [30, 421, TMS derivatiza- 
tion for sensitivity enhancement 131-331, and daugh- 
ters of the BH; ion for structure characterization [31]. 
FAB ionization with CNL scans of MSTFA deriva- 
tized samples allowed identification of carcinogen-de- 
oxynucleoside adducts at levels as low as 1 ng. For a 
carcinogen-nucleoside adduct with a molecular weight 
of 500 u, this corresponds to about 2 pmol. With this 
detection limit the analysis of in vivo samples from 
animals dosed with carcinogens should be possible 
based on one adduct per lo6 nucleotides (manuscript 
in preparation). 
Daughter ion scans were used to differentiate C-8 
substituted arylamine adducts of deoxyadenosine and 
deoxyguanosine by using the BH: ion as the parent. 
FOK dG-C8-ABP this fragment ion showed the same 
daughter ion spectrum as the protonated molecule of 
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the carcinogen-base, G-CSABP. Fragmentation of the 
BH: parent ions was largely in agreement with previ- 
ously reported results obtained by using high energy 
collisions. 
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